Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Higher CD 34 Cell Doses Reduce Non Relapse Mortality (NRM) and Do Not Increase the Incidence of Graft Versus Host Disease (GVHD) Following Unrelated Donor Blood Stem Cell Transplantation (SCT).

Sujaatha Narayanan, MBBS, Michael J. Barnett, BM, Yasser R. Abou Mourad, MD, Donna L. Forrest, MD, Donna E. Hogge, MD, Julye C. Lavoie, MD, Stephen H. Nantel, MD, John D. Shepherd, MD, Kevin W. Song, MD, Heather J. Sutherland, MD, Cynthia L. Toze, MD, Clayton A. Smith, MD, Maryse Power, MD, Thomas J. Nevill, MD

Blood (2007) 110 (11): 5091.

https://doi.org/10.1182/blood.V110.11.5091.5091

Published: 2007

Journal Articles

Stem Cell Transplantation (SCT) Improves Survival in Acute Biphenotypic (ABL) and Acute Undifferentiated Leukemia (AUL): A Single Centre Experience.

Blood (2007) 110 (11): 1093.

https://doi.org/10.1182/blood.V110.11.1093.1093

Published: 2007

Journal Articles

Allogeneic Stem Cell Transplant in First Complete Remission Overcomes the Poor Prognosis Associated with the FLT-3 Internal Tandem Duplication in Acute Myeloid Leukemia.

Maryse M. Power, MRCPI, MRCPath, Giovanna Di Sauro, Angela Brooks-Wilson, Thomas J. Nevill, MD, FRCPC, Julye C. Lavoie, MD, Clayton A. Smith, MD, John D. Shepherd, MD, FRCPC, Cindy L. Toze, MD, FRCPC, MHSc, Heather J. Sutherland, MD, FRCPC, PhD, Michael J. Barnett, MB, FRCPath, Yasser A. Abou Mourad, MD, Kevin W. Song, MD, FRCPC, Donna M. Forrest, MD, FRCPC, Steven H. Nantel, MD, FRCPC, Stanley C. Wong, Anna A. Krasnova, Ryan Brinkman, PhD, Donna E. Hogge, MD, PhD, FRCPC

Blood (2007) 110 (11): 3491.

https://doi.org/10.1182/blood.V110.11.3491.3491

Published: 2007

Journal Articles

Long-Term Follow-Up Results of Adults with T-Cell Acute Lymphoblastic Leukemia (T-ALL)-The Vancouver Experience.

Yasser R. Abou Mourad, MD, Stephen H. Nantel, MD, Cynthia L. Toze, MD, Thomas J. Nevill, MD, Michael J. Barnett, BM, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Julye C. Lavoie, MD, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Clayton A. Smith, MD, Kevin W. Song, MD

Blood (2005) 106 (11): 4578.

https://doi.org/10.1182/blood.V106.11.4578.4578

Published: 2005

Journal Articles

Second Solid Cancers after Allogeneic Stem Cell Transplantation: The Vancouver Experience.

Genevieve Gallagher, MD, Donna E. Hogge, MD, Thomas J. Nevill, MD, Stephen H. Nantel, MD, Michael J. Barnett, MD, John D. Shepherd, MD, Heather J. Sutherland, MD, Cynthia L. Toze, MD, Clayton A. Smith, MD, Julye C. Lavoie, MD, Kevin W. Song, MD, Donna L. Forrest, MD

Blood (2005) 106 (11): 1120.

https://doi.org/10.1182/blood.V106.11.1120.1120

Published: 2005

Journal Articles

High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver

Julye C. Lavoie, Joseph M. Connors, Gordon L. Phillips, Donna E. Reece, Michael J. Barnett, Donna L. Forrest, Randy D. Gascoyne, Donna E. Hogge, Stephen H. Nantel, John D. Shepherd, Clayton A. Smith, Kevin W. Song, Heather J. Sutherland, Cynthia L. Toze, Nicholas J. S. Voss, Thomas J. Nevill

Blood (2005) 106 (4): 1473–1478.

https://doi.org/10.1182/blood-2004-12-4689

Published: 2005

Journal Articles

High Risk AML Outpatient Management: A Retrospective Analysis of Bacteremia Incidence Following Chemotherapy.

Timotheus Y. Halim, Julye C. Lavoie, MD, Michael J. Barnett, MD, Stephen H. Nantel, MD, Thomas J. Nevill, MD, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Donna E. Hogge, MD, PhD, Kevin W. Song, MD, Donna L. Forrest, MD, Cynthia L. Toze, MD, Clay A. Smith, MD

Blood (2004) 104 (11): 884.

https://doi.org/10.1182/blood.V104.11.884.884

Published: 2004

Journal Articles

Hematopoietic Stem Cell Transplant (HSCT) as Primary Treatment for T-Cell Lymphobastic Lymphoma (T-LBL) : An Intention to Treat Analysis.

Kevin W. Song, MD, Thomas J. Nevill, MD, Randy D. Gascoyne, MD, Cynthia L. Toze, MD, Michael B. Barnett, MD, Donna L. Forrest, MD, Donna E. Hogge, MD, Julye C. Lavoie, MD, Stephen H. Nantel, MD, John D. Shepherd, MD, Clayton A. Smith, MD, Heather J. Sutherland, MD, Nicholas J. Voss, MD, Joseph M. Connors, MD

Blood (2004) 104 (11): 900.

https://doi.org/10.1182/blood.V104.11.900.900

Published: 2004

Journal Articles

Acceptable Outcomes for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) for Relapsed Aggressive Non-Hodgkin’s Lymphoma (NHL).

Richard T. Doocey, MBChB, Kevin W. Song, MD, Cynthia L. Toze, MD, Joseph M. Connors, MD, Thomas J. Nevill, MD, Randy D. Gascoyne, MD, Michael J. Barnett, BM, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Julye C. Lavoie, MD, Stephen H. Nantel, MD, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Nicholas Voss, MD, Clayton A. Smith, MD

Blood (2004) 104 (11): 3325.

https://doi.org/10.1182/blood.V104.11.3325.3325

Published: 2004

Journal Articles

Risk Stratification in Acute Promyelocytic Leukemia Based on Elevated White Cell Count and Reduced Platelet Count Does Not Identify Subsequent Relapses: A Retrospective Review of 60 Patients.

Richard T. Doocey, MBChB, Stephen H. Nantel, MD, Michael J. Barnett, BM, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Julye C. Lavoie, MD, Thomas J. Nevill, MD, John D. Shepherd, MD, Kevin W. Song, MD, Heather J. Sutherland, MD, PhD, Cynthia L. Toze, MD, Clayton A. Smith, MD

Blood (2004) 104 (11): 4522.

https://doi.org/10.1182/blood.V104.11.4522.4522

Published: 2004

Journal Articles

Philadelphia-Negative Clonal Hematopoiesis Following Imatinib Therapy in Patients with Chronic Myeloid Leukemia (CML).

Yulia Lin, MD, Helene Bruyere, MD, Douglas E. Horsman, MD, Michael J. Barnett, BM, Donna E. Hogge, MD, PhD, Thomas J. Nevill, MD, Stephen H. Nantel, MD, Heather J. Sutherland, MD, PhD, Cynthia L. Toze, MD, John D. Shepherd, MD, Julye C. Lavoie, MD, Kevin W. Song, MD, Clayton A. Smith, MD, Donna L. Forrest, MD

Blood (2004) 104 (11): 4696.

https://doi.org/10.1182/blood.V104.11.4696.4696

Published: 2004

Journal Articles

Septicemia in Chemotherapy Induced Neutropenic Acute Myeloid Leukemia (AML) Inpatients and Outpatients: A 5 Year Retrospective Experience.

Timotheus Y. Halim, Julye C. Lavoie, MD, Micheal J. Barnett, MD, Donna L. Forest, MD, Donna E. Hogge, MD, PhD, Stephen H. Nantel, MD, Thomas J. Nevill, MD, John D. Shepherd, MD, Kevin W. Song, MD, Heather J. Sutherland, MD, PhD, Cynthia L. Toze, MD, Clay A. Smith, MD

Blood (2004) 104 (11): 4525.

https://doi.org/10.1182/blood.V104.11.4525.4525

Published: 2004

Journal Articles

Daclizumab Therapy Improves Outcome in Steroid Refractory Acute Graft Versus Host Disease (aGVHD).

Richard T. Doocey, MBChB, Matthew J. Greenwood, BMed, Dawn Warkentin, Kevin W. Song, MD, Alan Le, Janet Nitta, Thomas J. Nevill, MD, Michael J. Barnett, MD, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Julye C. Lavoie, MD, Stephen H. Nantel, MD, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Cynthia L. Toze, MD, Clayton A. Smith, MD

Blood (2004) 104 (11): 5092.

https://doi.org/10.1182/blood.V104.11.5092.5092

Published: 2004

Journal Articles

Long-Term Results of Allogeneic Hematopoietic Stem Cell Transplantation Using Unrelated or HLA Mismatched Family Donors for Acute and Chronic Lymphoid Malignancy.

Cynthia L. Toze, Donna E. Hogge, Michael J. Barnett, Thomas J. Nevill, Stephen H. Nantel, Heather J. Sutherland, John D. Shepherd, Kevin W. Song, Donna L. Forrest, Julye C. Lavoie, Joseph M. Connors, Randy D. Gascoyne, Nicholas J. Voss, Clayton A. Smith

Blood (2004) 104 (11): 2764.

https://doi.org/10.1182/blood.V104.11.2764.2764

Published: 2004

Journal Articles

Salvage of Primary Refractory Acute Leukemia (AL) with High-Dose Etoposide (VP) and Cyclophosphamide (CY) Followed by Early Stem Cell Transplantation (SCT): An Effective Treatment Strategy for AML but Not for All.

Thomas J. Nevill, MD, Asha Johny, MD, Kevin W. Song, MD, Julye C. Lavoie, MD, Cynthia L. Toze, MD, Michael J. Barnett, BM, Donna E. Hogge, MD, John D. Shepherd, MD, Janet Y. Nita, Alan Le, Heather J. Sutherland, MD, Clayton A. Smith, MD, Donna L. Forrest, MD, Stephen H. Nantel, MD

Blood (2004) 104 (11): 5152.

https://doi.org/10.1182/blood.V104.11.5152.5152

Published: 2004

NARROW

Higher CD 34 Cell Doses Reduce Non Relapse Mortality (NRM) and Do Not Increase the Incidence of Graft Versus Host Disease (GVHD) Following Unrelated Donor Blood Stem Cell Transplantation (SCT).

Stem Cell Transplantation (SCT) Improves Survival in Acute Biphenotypic (ABL) and Acute Undifferentiated Leukemia (AUL): A Single Centre Experience.

Allogeneic Stem Cell Transplant in First Complete Remission Overcomes the Poor Prognosis Associated with the FLT-3 Internal Tandem Duplication in Acute Myeloid Leukemia.

Long-Term Follow-Up Results of Adults with T-Cell Acute Lymphoblastic Leukemia (T-ALL)-The Vancouver Experience.

Second Solid Cancers after Allogeneic Stem Cell Transplantation: The Vancouver Experience.

High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver

High Risk AML Outpatient Management: A Retrospective Analysis of Bacteremia Incidence Following Chemotherapy.

Hematopoietic Stem Cell Transplant (HSCT) as Primary Treatment for T-Cell Lymphobastic Lymphoma (T-LBL) : An Intention to Treat Analysis.

Acceptable Outcomes for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) for Relapsed Aggressive Non-Hodgkin’s Lymphoma (NHL).

Risk Stratification in Acute Promyelocytic Leukemia Based on Elevated White Cell Count and Reduced Platelet Count Does Not Identify Subsequent Relapses: A Retrospective Review of 60 Patients.

Philadelphia-Negative Clonal Hematopoiesis Following Imatinib Therapy in Patients with Chronic Myeloid Leukemia (CML).

Septicemia in Chemotherapy Induced Neutropenic Acute Myeloid Leukemia (AML) Inpatients and Outpatients: A 5 Year Retrospective Experience.

Daclizumab Therapy Improves Outcome in Steroid Refractory Acute Graft Versus Host Disease (aGVHD).

Long-Term Results of Allogeneic Hematopoietic Stem Cell Transplantation Using Unrelated or HLA Mismatched Family Donors for Acute and Chronic Lymphoid Malignancy.

Salvage of Primary Refractory Acute Leukemia (AL) with High-Dose Etoposide (VP) and Cyclophosphamide (CY) Followed by Early Stem Cell Transplantation (SCT): An Effective Treatment Strategy for AML but Not for All.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only